125 related articles for article (PubMed ID: 38453411)
1. Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment of
Ramakrishnan D; Brüningk SC; von Reppert M; Memon F; Maleki N; Aneja S; Kazerooni AF; Nabavizadeh A; Lin M; Bousabarah K; Molinaro A; Nicolaides T; Prados M; Mueller S; Aboian MS
AJNR Am J Neuroradiol; 2024 Apr; 45(4):475-482. PubMed ID: 38453411
[TBL] [Abstract][Full Text] [Related]
2. Comparison of volumetric and 2D-based response methods in the PNOC-001 pediatric low-grade glioma clinical trial.
von Reppert M; Ramakrishnan D; Brüningk SC; Memon F; Abi Fadel S; Maleki N; Bahar R; Avesta AE; Jekel L; Sala M; Lost J; Tillmanns N; Kaur M; Aneja S; Fathi Kazerooni A; Nabavizadeh A; Lin M; Hoffmann KT; Bousabarah K; Swanson KR; Haas-Kogan D; Mueller S; Aboian MS
Neurooncol Adv; 2024; 6(1):vdad172. PubMed ID: 38221978
[TBL] [Abstract][Full Text] [Related]
3. MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.
Shrot S; Kerpel A; Belenky J; Lurye M; Hoffmann C; Yalon M
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1356-1362. PubMed ID: 36007944
[TBL] [Abstract][Full Text] [Related]
4. MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation of
Trasolini A; Erker C; Cheng S; Crowell C; McFadden K; Moineddin R; Sargent MA; Mata-Mbemba D
AJNR Am J Neuroradiol; 2022 Aug; 43(8):1196-1201. PubMed ID: 35863783
[TBL] [Abstract][Full Text] [Related]
5. Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of
Wagner MW; Hainc N; Khalvati F; Namdar K; Figueiredo L; Sheng M; Laughlin S; Shroff MM; Bouffet E; Tabori U; Hawkins C; Yeom KW; Ertl-Wagner BB
AJNR Am J Neuroradiol; 2021 Apr; 42(4):759-765. PubMed ID: 33574103
[TBL] [Abstract][Full Text] [Related]
6. Radiomics features based on MRI predict BRAF V600E mutation in pediatric low-grade gliomas: A non-invasive method for molecular diagnosis.
Xu J; Lai M; Li S; Ye K; Li L; Hu Q; Ai R; Zhou J; Li J; Zhen J; Cai L; Shi C
Clin Neurol Neurosurg; 2022 Nov; 222():107478. PubMed ID: 36244075
[TBL] [Abstract][Full Text] [Related]
7. Volumetric assessment of tumor size changes in pediatric low-grade gliomas: feasibility and comparison with linear measurements.
D'Arco F; O'Hare P; Dashti F; Lassaletta A; Loka T; Tabori U; Talenti G; Thust S; Messalli G; Hales P; Bouffet E; Laughlin S
Neuroradiology; 2018 Apr; 60(4):427-436. PubMed ID: 29383433
[TBL] [Abstract][Full Text] [Related]
8. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.
Shah GD; Kesari S; Xu R; Batchelor TT; O'Neill AM; Hochberg FH; Levy B; Bradshaw J; Wen PY
Neuro Oncol; 2006 Jan; 8(1):38-46. PubMed ID: 16443946
[TBL] [Abstract][Full Text] [Related]
9. A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation.
Ho CY; Mobley BC; Gordish-Dressman H; VandenBussche CJ; Mason GE; Bornhorst M; Esbenshade AJ; Tehrani M; Orr BA; LaFrance DR; Devaney JM; Meltzer BW; Hofherr SE; Burger PC; Packer RJ; Rodriguez FJ
Acta Neuropathol; 2015 Oct; 130(4):575-85. PubMed ID: 26264609
[TBL] [Abstract][Full Text] [Related]
10. T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.
Wagner MW; Nobre L; Namdar K; Khalvati F; Tabori U; Hawkins C; Ertl-Wagner BB
AJNR Am J Neuroradiol; 2023 Jul; 44(7):841-845. PubMed ID: 37348970
[TBL] [Abstract][Full Text] [Related]
11. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
[TBL] [Abstract][Full Text] [Related]
13. Dabrafenib plus trametinib in patients with BRAF
Wen PY; Stein A; van den Bent M; De Greve J; Wick A; de Vos FYFL; von Bubnoff N; van Linde ME; Lai A; Prager GW; Campone M; Fasolo A; Lopez-Martin JA; Kim TM; Mason WP; Hofheinz RD; Blay JY; Cho DC; Gazzah A; Pouessel D; Yachnin J; Boran A; Burgess P; Ilankumaran P; Gasal E; Subbiah V
Lancet Oncol; 2022 Jan; 23(1):53-64. PubMed ID: 34838156
[TBL] [Abstract][Full Text] [Related]
14. Comparison of linear and volumetric criteria for the determination of therapeutic response in dogs with intracranial gliomas.
Garcia Mora JK; Robertson J; Hsu FC; Shinn RL; Larson MM; Rylander CG; Whitlow CT; Debinski W; Davalos RV; B Daniel G; Rossmeisl JH
J Vet Intern Med; 2022 May; 36(3):1066-1074. PubMed ID: 35274379
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
Martin AM; Bell WR; Yuan M; Harris L; Poore B; Arnold A; Engle EL; Asnaghi L; Lim M; Raabe EH; Eberhart CG
J Neuropathol Exp Neurol; 2020 Jan; 79(1):74-85. PubMed ID: 31819973
[TBL] [Abstract][Full Text] [Related]
16. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type.
Ramaglia A; Tortora D; Mankad K; Lequin M; Severino M; D'Arco F; Löbel U; Benenati M; de Leng WWJ; De Marco P; Milanaccio C; Rossi A; Morana G
Neuroradiology; 2020 Jan; 62(1):71-80. PubMed ID: 31667545
[TBL] [Abstract][Full Text] [Related]
17. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.
Galanis E; Buckner JC; Maurer MJ; Sykora R; Castillo R; Ballman KV; Erickson BJ
Neuro Oncol; 2006 Apr; 8(2):156-65. PubMed ID: 16533757
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
[TBL] [Abstract][Full Text] [Related]
19. ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium.
Vajapeyam S; Brown D; Ziaei A; Wu S; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Jones BV; Yeom KW; Onar-Thomas A; Dunkel IJ; Fouladi M; Fangusaro JR; Poussaint TY
AJNR Am J Neuroradiol; 2022 Mar; 43(3):455-461. PubMed ID: 35210278
[TBL] [Abstract][Full Text] [Related]
20. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.
Ellingson BM; Kim GHJ; Brown M; Lee J; Salamon N; Steelman L; Hassan I; Pandya SS; Chun S; Linetsky M; Yoo B; Wen PY; Mellinghoff IK; Goldin J; Cloughesy TF
Neuro Oncol; 2022 May; 24(5):770-778. PubMed ID: 34751786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
